Titin-truncating variants (TTNtv) commonly cause dilated cardiomyopathy (DCM). TTNtv are also encountered in ~1% of the general population, where they may be silent, perhaps reflecting allelic factors. To better understand TTNtv, we integrated TTN allelic series, cardiac imaging and genomic data in humans and studied rat models with disparate TTNtv. In patients with DCM, TTNtv throughout titin were significantly associated with DCM. Ribosomal profiling in rat showed the translational footprint of premature stop codons in Ttn, TTNtv-position-independent nonsense-mediated degradation of the mutant allele and a signature of perturbed cardiac metabolism. Heart physiology in rats with TTNtv was unremarkable at baseline but became impaired during cardiac stress. In healthy humans, machine-learning-based analysis of high-resolution cardiac imaging showed TTNtv to be associated with eccentric cardiac remodeling. These data show that TTNtv have molecular and physiological effects on the heart across species, with a continuum of expressivity in health and disease.
DCM has a prevalence of up to 1:250 (ref. 1) , is the most common indication for heart transplantation and is often associated with TTNtv (15-20% of DCM cases), which are enriched in the titin A-band 2, 3 . A surprising ~1% of the general population has a TTNtv in the absence of DCM, which has stimulated much debate as to the pathogenicity of TTNtv [4] [5] [6] [7] . It has been suggested that TTNtv in the healthy population may be phenotypically silent and that TTNtv that segregate in familial DCM are perhaps modifiers of other DCMcausing variants 3 . However, it is also known that variants in diseaselinked genes can be associated with quantitative differences in the physiology of healthy individuals 8 , and such a possibility has not been formally assessed for TTNtv.
We showed previously that TTN exon characteristics are important determinants of TTNtv pathogenicity. Variants encoded in exons that are not spliced into titin isoforms expressed in the heart (non-cardiac exons with percent spliced in (PSI) <15%) are not associated with DCM 3 , whereas variants encoded in exons that only incorporate into the N2BA isoform and not the N2B isoform have weak associations with disease. Studies of human induced pluripotent stem cell (iPSC)derived cardiomyocytes (iPSC-CMs) 9 showed that alternative exon splicing is a major mechanism of reduced penetrance for some I-band TTNtv. When only taking into account TTNtv that are encoded in cardiac exons (PSI > 15%), approximately 0.5% of the general population has a TTNtv that might be expected to cause DCM but does not.
In addition to the complexities surrounding TTNtv penetrance, the molecular mechanisms underlying pathogenesis mediated by TTNtv are uncharacterized. Neither nonsense-mediated mRNA decay (NMD) of the mutated allele, detected by RNA-seq, nor a reduction in the levels of full-length TTN, determined by agarose gel analysis, have been demonstrated, which if documented would support a haploinsufficient disease mechanism 3, 9, 10 . Equally, accumulation of a truncated titin protein is not apparent in human heart samples 3 and is rarely present in iPSC-CMs 9 , suggesting that a poison-peptide/ dominant-negative mechanism is unlikely.
Titin-truncating variants affect heart function in disease cohorts and the general population Here we undertook studies of human patients with DCM, rat models of TTNtv and human volunteers from the general population to better understand TTNtv pathogenicity and molecular effect, with a specific focus on dissecting a hypothesized position-dependent effect on the penetrance of TTNtv alleles. To do this, we performed a metaanalysis of TTNtv in patients with DCM (n = 2,495) as compared to controls (n = 61,834) and generated two rat models of TTNtv with variants at opposite ends of the titin molecule. We integrated RNA-seq and ribosome profiling (Ribo-seq) data across models and species, and we performed metabolic and signaling studies to outline potential disease mechanisms. To define the effects of TTNtv on the heart in the general population, we sequenced TTN in healthy volunteers (n = 1,409) who were deeply phenotyped. We supplemented standard 2D cardiac magnetic resonance imaging (CMR) with high-resolution, high-fidelity 3D CMR, integrating and analyzing the imaging and sequencing data using machine learning techniques.
RESULTS

TTNtv across the titin molecule are associated with DCM
We and others have shown that A-band TTNtv are associated with DCM 2,3,9 , but association of TTNtv in the I-band, Z-disc or M-line with DCM has not been demonstrated. It has been suggested that proximal (near N-terminus) TTNtv in particular may be non-penetrant. To investigate variant effects across the titin molecule, we retrieved TTNtv alleles from patients with DCM in available sources, combined these data with those for new DCM cases (n = 1,105) and performed a metaanalysis using the Exome Aggregation Consortium (ExAC) database 11 and other controls (cohort totals: DCM cases, n = 2,495; controls, n = 61,834; Online Methods). This analysis showed that TTNtv encoded in constitutive exons (PSI > 90%) were significantly associated with DCM, irrespective of their position in titin ( Table 1) .
While some I-band TTNtv may be rescued by differential splicing 9 , we observed that I-band TTNtv encoded in constitutive cardiac exons were significantly associated with DCM, which was true for both proximal and distal I-band variants. TTNtv in Z-disc-encoding exons were also associated with DCM, although with a much lower odds ratio (OR = 5.3) than was found for A-band TTNtv (OR = 49.8). It has been proposed that a distal internal promoter of the Cronos titin isoform 12 , which we confirmed to be present in adult human heart using cap analysis of gene expression (CAGE) 13 data ( Supplementary  Fig. 1 ), can rescue proximal TTNtv effects. However, we found that proximal TTNtv were also penetrant and associated with DCM. By splitting titin into protein regions ( Table 1 ) or consecutive uniformly sized bins (n = 40; Supplementary Fig. 2 ), we were able to show that the fraction of truncating variants that were penetrant (etiological fraction) in regions of titin encoded upstream of the Cronos promoter was comparable to the fraction in the downstream A-band. These data show that distal I-band and all A-band TTNtv have larger odds ratios than very proximal or distal variants, suggesting position-dependent effects on the penetrance of TTNtv in DCM.
Premature stop codons cause nonsense-mediated mRNA decay and disrupt translation of full-length, sarcomere-spanning titin
Our meta-analyses of patients with DCM showed that TTNtv throughout the titin molecule are penetrant but have variable, position-related odds ratios. To study putative position-dependent effects in greater detail while controlling for other genetic and non-genetic factors, we modeled proximal and distal TTNtv in two independent rat strains on the same genetic background (TTNtvA, variation in the A-band; TTNtvZ, variation in the Z-disc; for details, see Supplementary  Fig. 3 ). Rats with homozygous mutations were not viable, as previously described for TTNtv in mice 10 , while heterozygous rats were born in normal Mendelian ratios (data not shown).
We bred TTNtv heterozygous rats on a F344 background with Brown Norway rats with wild-type Ttn to obtain an F 1 cross to enable allele-specific analysis of Ttn transcription and translation in the hearts of TTNtvA (n = 3), TTNtvZ (n = 3) and wild-type (n = 4) rats using RNA-seq and Ribo-seq ( Fig. 1a and Supplementary  Fig. 4 ) 14, 15 . Ribosome-protected fragments (RPFs) showed clear trinucleotide periodicity across the translatome, indicating the presence of actively translating ribosomes ( Fig. 1b) . Ttn transcripts encoding a truncation in the A-band were transcribed and translated as far as the nonsense codon, which efficiently stopped translation thereafter ( Fig. 1c,d) .
The premature stop codon of the TTNtvZ allele did not prevent translation downstream of the non-canonical stop codon, and F344 SNPs on the Ttn allele encoding the truncation were detected throughout Ttn (Fig. 1e) . Rescue of translation from the truncating F344 allele did not decrease the 3-nt periodicity across Ttn in comparison to F 1 wild-type rats that synthesized titin from two intact alleles ( Fig. 1f) . Exon-level analyses showed that the TTNtvZ variant initially reduced ribosome occupancy at the 5′ end of Ttn (~50% that of wild-type occupancy), but translation was subsequently partially recovered ( Fig. 1g) . This apparent rescue of translation might be explained in part by internal ribosomal entry sites (IRES), by transcription start sites that generate titin isoforms with alternative N termini, and potentially by factors that maintain ribosomes on the long Ttn transcript during its translation. In support of this hypothesis, human CAGE data 13 and analysis of epigenetic marks 16 identified distal TTN promoters in human heart ( Supplementary Fig. 1 ), as previously suggested 12 . In TTNtvA rats, we only detected ribosomes on the intact BN allele after the premature stop codon (Fig. 1c) . This led to a decrease in ribosome occupancy of 50% when compared to wild-type rats that translated this section of Ttn from both alleles ( Fig. 1g) .
In both mutant rats, there was a relative increase in the frequency of exon translation in the I-band ( Fig. 1g ) that reflects differential Ttn mRNA processing and higher PSI ratios 17 for exons in the I-band, as observed in human iPSC-CMs with TTNtv 9 . This is indicative of an increase in expression of the N2BA isoform in TTNtv carriers. To determine whether this finding would translate to humans, we compared cardiac RNA-seq data 3 from human DCM cases with (n = 17) and without (n = 91) a TTNtv and observed similar patterns of alternative splicing in TTNtv carriers as were seen in the rat models ( Fig. 2a) . Allele-specific RNA-seq data showed slight upregulation of the wild-type allele and profound NMD of the allele carrying the TTNtv in both the TTNtvA and TTNtvZ models ( Fig. 2b) . These data demonstrate a multiallelic effect of TTNtv on the overall titin isoform composition across species (that can cause DCM 18, 19 ) and that TTNtv confer position-independent NMD.
It is notable that both the proximal and distal TTNtv triggered NMD with identical efficiency, irrespective of their locations in the titin molecule. The fact that the proximal truncating variant triggers NMD indicates that the premature stop codon close to the 5′ end of the TTNtvZ allele is functional and that ribosomes cannot clear exon-exon junction complexes 20, 21 . Assessing translation beyond the truncating variant in the TTNtvA transcript and the four-exon deletion in the TTNtvZ transcript showed that both rat models synthesized lesser amounts (~60% of those in wild-type rats) of full-length, sarcomere-spanning titin (Fig. 2c) . In keeping with our published data 3 , protein gel electrophoresis did not identify a truncated titin isoform or a reduction in the titin/Mhc ratio in mutant rat heart ( Supplementary Fig. 5 ). This result suggests rapid turnover of mutant protein that, to our knowledge, we document the existence of for the first time by showing its synthesis ( Fig. 1) . It also shows that, although there are significantly fewer ribosomes translating full-length protein (f) Ribo-seq reads located downstream of the TTNtvZ premature stop codon do not show decreased 3-nt periodicity, suggesting that TTNtvZ rats actively translate canonical Ttn sequence at similar levels as rats with two wild-type Ttn alleles. (g) In TTNtvZ rats, ribosome density is initially reduced, but translation of Ttn is gradually rescued. Translation of A-band exons, but not of I-band exons, is reduced in mutants in comparison to wild-type rats. In TTNtvA rats, translation is efficiently reduced after the premature stop codon.
in the mutants (TTNtvA: P = 0.014; TTNtvZ: P = 0.027), changes in titin protein levels are not apparent at the resolution of gel analysis.
Overall changes in the levels of full-length titin protein might be compensated for not just by upregulation of the wild-type allele (P = 0.02; Fig. 2b ) but also via an increase in ribosome translational speed or changes in protein turnover. Taken together, these data indicate that proximal and distal TTNtv disrupt titin protein synthesis but have different translational footprints. However, the effects of these variants on NMD of the transcripts encoding sarcomere-spanning titin isoforms are similar, leading to identical reductions in the expression of full-length titin.
Titin truncations cause position-independent perturbation of cardiac metabolism and signaling
To determine whether distinct molecular phenotypes are associated with proximal and distal TTNtv, we performed pathway analysis 22 of the genome-wide transcription (RNA-seq) and translation (Ribo-seq) profiles for the TTNtvZ and TTNtvA mutants as compared to controls. The gene expression differences observed between TTNtv rats and wild-type controls were highly correlated for TTNtvA and TTNtvZ, both for the RNA-seq and Ribo-seq data, showing that the mutant strains have similarly perturbed transcriptomes (R 2 = 0.841, P < 0.0001) and translatomes (R 2 = 0.837, P < 0.0001; Supplementary  Fig. 6 and Supplementary Table 1 ). Gene set enrichment analyses showed significantly overlapping Kyoto Encyclopedia of Genes and Genomes (KEGG) 22, 23 terms for TTNtv rats when compared to wild-type controls (RNA-seq P < 1 × 10 −15 , Ribo-seq P < 1 × 10 −15 , Pearson χ 2 test; Fig. 3a) , which suggests altered cardiac metabolism independent of the positions of the TTNtv.
To investigate further the molecular signatures of altered cardiac metabolism in mutant rats, we performed quantitative metabolomic profiling of hearts from wild-type and TTNtv rats. Liquid A r t i c l e s chromatography coupled with mass spectrometry (LC-MS) showed reduced amounts of medium-and long-chain fatty acid acylcarnitines in hearts from TTNtv rats as compared to controls ( Fig. 3b and Supplementary Table 2 ). We also performed capillary electrophoresis coupled with mass spectrometry, which is complementary to LC-MS, and observed accumulation of alternative myocardial substrates (branched-chain amino acid metabolites and glycolytic intermediates) in mutants ( Fig. 3c-e, Supplementary Fig. 7 and Supplementary  Table 3 ). These changes are similar to those seen in the failing heart and the pressure-loaded non-failing heart 24, 25 and are associated with a shift in cardiac metabolism away from fatty acids and toward glycolysis, which may be adaptive [26] [27] [28] . There was no change in the amounts of major energy substrates (for example, ATP; Supplementary Fig. 8) , which are only diminished in advanced cardiac failure 29 . The signaling changes in the heart due to TTNtv are likely many. We found that variations in the amounts of metabolic proteins that interact with titin, such as Fhl2 ( Supplementary Fig. 9 ), were small, and the functional roles of these changes cannot be established on the basis of these data alone. It is known that mTORC1 signaling is activated in familial DCM 30 , and the activity of this pathway is detrimental in a mouse model of DCM due to Lmna mutation 31 . We profiled the mTORC1 pathway in hearts from TTNtv rats, where the levels of metabolites activating mTOR 32 were elevated (Fig. 3) , and observed activation of signaling ( Supplementary Fig. 10 ). The relative importance of such signaling variation for DCM pathobiology remains to be established.
TTNtv impair cardiac performance during stress in rats and have adverse effects on the heart in the general human population
In young TTNtv rats (<8 months old), cardiac imaging showed features of concentric remodeling but normal left ventricle mass and systolic function ( Supplementary Fig. 11 ). In older rats (>1 year old), TTNtv hearts were similar to controls, although with a suggestion of slightly impaired systolic function ( Fig. 4a and Supplementary Fig. 12 ). Although changes in cardiac morphology and function were mild in young mutant rats, it is possible that this phenotype represents a compensated state, as evidenced by the shift in cardiac metabolism (Fig. 3) , which is adaptive, at least in the short term 26 . We examined cardiac function ex vivo and used a volume overload model to test Frank-Starling response, which may specifically be impaired by genetic variation in TTN 33 . Under basal conditions (left ventricle end diastolic pressure of 5-10 mm Hg), rat hearts harboring TTNtv tended to have higher strain rates and left ventricle developed pressures, perhaps reflecting compensatory metabolism ( Fig. 3) and signaling ( Supplementary  Fig. 10) ; however, when hearts were subjected to stress from sequential volume overload, mutant heart function became increasingly impaired (Fig. 4b) . As observed previously [34] [35] [36] , cardiac stress ex vivo activated mTORC1 signaling in control rats, which is an adaptive response. However, hearts harboring TTNtv had elevated mTORC1 signaling at baseline and were not able to appropriately increase mTORC1 activity further when stressed (Supplementary Fig. 10) .
In rat, TTNtv had mild effects on heart function irrespective of their positions in the titin molecule but did not cause DCM. To explore the possibility that TTNtv in cardiac exons similarly affect the heart in human subjects, irrespective of disease status, we recruited 1,409 healthy individuals for detailed CMR studies of the heart in combination with TTN sequencing. We specifically focused our studies on the cardiac parameters of left ventricle end diastolic volume (LVEDV) and ejection fraction (EF), which are used to define DCM 37 , and also left ventricle end systolic volume (LVESV), which is elevated in pre-DCM cases and predicts the onset of heart failure 38 . In this cohort, we identified 15 TTNtv ( Supplementary Table 4 ; prevalence = 1.0%) in TTN exons (PSI > 15%), in keeping with our previous findings 3 and data from ExAC 11 . Variants resulting in truncation were equally distributed across the titin molecule in our cohort and in the ExAC data set (Supplementary Fig. 13) .
After genotype-blinded analysis of CMR data, we found that no individual from the general population with a TTNtv met imaging criteria for DCM, similar to our observations in the rat models and previous studies 3 . However, in univariate analyses, TTNtv conferred a significant increase in absolute left ventricle volume and had pronounced effects on volume indexed to body surface area (Fig. 4c) . There was a non-significant trend toward lower left ventricle ejection fraction in individuals harboring TTNtv (LVEF (%): TTNtv positive, 66 ± 5; TTNtv negative, 63 ± 5; P = 0.06, Mann-Whitney test). Given the multiple clinical and anthropometric variables that predict cardiac morphology and function, we built regression models for LVEDV, LVESV and LVEF (Online Methods and Supplementary Table 5 ) and tested whether addition of TTNtv status improved model performance, which turned out to be the case (absolute β values: LVEDV, +11.8 ml (8.1%); LVESV, +7.7 ml (15%); LVEF, −2.8%; P < 0.03 for all). Of note, the effect size of TTNtv on cardiac parameters was much greater than the effect sizes of loci identified by cardiovascular genome-wide association studies (GWAS; for example, systolic blood pressure, for which the combined effect of all GWAS-identified loci was ~3%) 39, 40 .
To complement our 2D studies, we collected an independent data set of high-resolution, single-breath-hold 3D CMR images and, blinded to genotype, performed atlas-and machine-learning-based analyses of left ventricle geometry with respect to TTNtv status 41, 42 . The 3D data showed that TTNtv were associated with eccentric cardiac remodeling in healthy individuals. This remodeling was defined by outward displacement of the endocardial border of the heart (Fig. 4d,e and Supplementary Video 1) in both systole (79% of total surface, P < 0.05) and diastole (47% of total surface, P < 0.05), in consensus with the 2D data showing larger left ventricle volumes at these phases of the cardiac cycle.
DISCUSSION
Here we studied the effects of TTNtv in patients with DCM, in the rat and in healthy humans to better understand these variants that represent the most common genetic cause of DCM, yet are prevalent in the general population. At the molecular level, we found that TTNtv cause altered I-band splicing and position-independent NMD, which attenuates the synthesis of sarcomere-spanning titin isoforms. The NMD of the TTNtv allele that we observed in the F 1 rat cross is, to our knowledge, the first demonstration of this effect and something we were not able to show previously using unphased human RNA-seq data 3 . Distal truncations are associated with synthesis of C-terminally truncated titin isoforms, whereas proximal TTNtv lead to translation of additional titin isoforms with alternative N termini. None of these additional isoforms were detected on protein gels, suggesting that these species are rapidly degraded (Supplementary Fig. 5 ). It was notable that, irrespective of their position in the titin molecule, proximal and distal premature stop codons in rat caused highly similar gene expression and translational signatures. While these molecular phenotypes are sufficient to affect heart function, these findings do not exclude the possibility of additional, position-dependent effects that modify TTNtv penetrance in DCM, where distal I-band and all A-band TTNtv have the highest odds ratios.
The molecular phenotype due to TTNtv, which is reminiscent of cardiac adaptation to heart failure stimuli with a shift away from fatty acid metabolism [26] [27] [28] , was associated with activation of the mTORC1 pathway, which is also activated in familial DCM 30 . We suggest that the metabolic (Fig. 3) and signaling (Supplementary Fig. 10 ) changes in hearts harboring TTNtv represent adaptive mechanisms [26] [27] [28] and that the heart is maintained in a compensated state and is therefore inflexible to further stress. This may explain why hemodynamic stress associated with pregnancy or possibly a second genetic factor may uncover TTNtv effects 43 . It will be interesting to see what other environmental triggers for DCM (for example, alcohol intake, viral infection or chemotherapy) combine with TTNtv to cause disease and equally to ascertain why some individuals with TTNtv and an interacting stimulus, such as pregnancy, do not develop disease.
We found that TTNtv in constitutive exons throughout the titin molecule, from the Z-disc to the M-line, are significantly associated with DCM. This has implications for interpretation of TTNtv in patients with DCM, although A-band and distal I-band TTNtv have higher odds ratios than variants in other titin domains, for reasons that remain unclear. In the general population, we show that TTNtv that were previously thought to be of limited consequence 44 are associated with higher left ventricular volume in 2D CMR analyses, which reflects underlying eccentric remodeling that was detected using advanced 3D CMR techniques. These data demonstrate the benefits of combining high-resolution phenotyping and machinebased data analysis for imaging genetic studies of the heart, which we suggest may be applied at scale in large cohorts with cardiac imaging and genetic data, such as the UK Biobank. It is apparent that the magnitude of the effects of TTNtv on cardiac geometry in the general population may be large enough to adversely influence future cardiac events in some individuals, and this requires further study.
We note that TTNtv in exons that are expressed in the heart (PSI > 15%) are present in about 0.5% of individuals across ancestry groups 3, 11 , and it may be that this variant class is of clinical relevance for up to 35 million people, particularly if they are exposed to additional genetic or environmental cardiac stresses. Future studies that pinpoint those at greatest risk from the interaction between a TTNtv and a secondary trigger, genetic or environmental, are needed to move the field forward.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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ONLINE METHODS
Rat studies. Rat TTNtv models were generated by SAGE Laboratories using zinc-finger nuclease-mediated gene targeting. Rats were maintained on a F344 background. For the A-band (C terminus)-truncating variant (TTNtvA), 12 bp were deleted and 2 bp were inserted (TA) at 228,608-228,619 to introduce a stop codon in exon 303 (RefSeq NC_005102.3) corresponding to exon 327 in the human sequence. For the Z-disc (N terminus)-truncating mutation (TTNtvZ) was generated by deletion of exons 2-6 (5,286-bp deletion, coordinates 2,323-7,608) to introduce a frameshift. For details, see Supplementary  Figure 1 . Genotypes were detected by PCR, and products were confirmed by Sanger sequencing. Rat studies were conducted in accordance with the principles and procedures outlined in the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee (2013/SHS/844) at the Duke-National University of Singapore Medical School.
To enable allele-specific expression analyses with RNA-seq and Ribo-seq, we crossed wild-type, TTNtvA and TTNtvZ F344 rats with healthy BN rats. These F 1 rats were only used for sequencing experiments. The wild-type strain carried one non-truncated BN Ttn allele and one non-truncated F344 Ttn allele. The TTNtvA and TTNtvZ strains carried one truncated F344 Ttn allele and one non-truncated BN Ttn allele.
Patient and control cohorts and rare TTNtv burden testing. Data were collated from previously published case series 2-4, alongside a new cohort of 1,105 patients with DCM and 571 healthy controls. Overall, TTN sequencing was performed in a total of 2,495 cases and 61,834 reference samples. The case cohorts included 689 previously published probands 3 , 241 previously published cases 2 (a UK cohort from this study, originally denoted DCM-B, was excluded because of overlap with the series from Roberts et al.), 156 probands referred to the Partners Healthcare Laboratory of Molecular Medicine for molecular diagnostics 45, 46 and 304 probands similarly referred to the Oxford Medical Genetics Laboratory (OMGL), UK 46 . Further prospective unselected patients with a diagnosis of DCM, confirmed using cardiac imaging with reference to established cardiac MRI or echocardiographic diagnostic criteria as previously described 3 , were recruited via the NIHR Royal Brompton Cardiovascular Biomedical Research Unit (n = 542), the German Center for Cardiovascular Research, Berlin (n = 386) and the National Heart Centre, Singapore (n = 177) and are reported here for the first time. These latter cohorts were sequenced on the Illumina MiSeq, Illumina NextSeq or Life Technologies SOLiD 5500xl platform after target enrichment using in-solution hybridization (Illumina Nextera 47 or Agilent SureSelect 3 ), with analysis using standard pipelines as previously described 3 . The research studies were approved by a research ethics committee, and all participants gave written informed consent.
Informatics pipelines were used to define TTNtv as previously described 3 . TTNtv included frameshift, non-canonical stop and essential splice-site variation.
Reference samples comprised the ExAC (n = 60,706) database 11 (version 0.3, January 2015), alongside 557 controls from our previous studies 2,3 after exclusion of control cohorts that overlapped with ExAC and 571 unpublished controls recruited at the National Heart Centre, Singapore.
Rare variants that were predicted to truncate full-length TTN were included in analyses (variants were defined as rare if thy had an ExAC minor allele frequency (MAF) <1 × 10 −4 ; variants were predicted to be truncating if they constituted a nonsense, frameshift insertion or deletion or disrupted a canonical splice donor/acceptor sequence; the TTN reference was the inferred complete meta-transcript LRG391_t1).
Variants were first grouped according to their location within the titin structure and expression of the exon in which they were found (PSI). We considered exons to be constitutive if they were spliced into at least 90% of the TTN transcripts present in the heart (PSI 90%). For each region, the prevalence of TTNtv in cases and controls were compared using the binomial test in R.
The constitutive TTN exons (plus 2-bp canonical splice sequences) were divided into 40 uniformly sized bins. For each bin, the total number of TTNtv alleles was compared in cases and controls, an odds ratio was computed and the etiological fraction (EF; the probability that an individual rare variant, found in a proband was responsible for the disease) was calculated using EF odds ratio odds ratio = − 1 as previously described 46 .
RNA-seq and Ribo-seq library preparation. To assess the translational status of wild-type and Ttn-mutant rats, ribosome profiling libraries were generated as previously described 15 . Briefly, ~70 mg of cardiac tissue was used for each animal and strain (wild-type, n = 4; TTNtvA, n = 3; TTNtvZ, n = 3) and subjected to cryolysis in 1 ml of lysis buffer (1× TruSeq Mammalian Polysome buffer (Illumina), 1% Triton X-100, 0.1% NP-40, 1 mM DTT, 10 U/ml DNase I and nuclease-free water) supplemented with 0.1 mg/ml cycloheximide (Sigma). Tissue was further homogenized using a 21-gauge syringe needle, incubated on ice for 10 min and centrifuged at 20,000g. 400 µl of lysate per sample was used to obtain ribosome footprints (RPFs) upon incubation with TruSeq Ribo Profile Nuclease (3 U per OD 260 /ml of lysate). RPF purification was performed using MicroSpin S-400 columns (GE Healthcare) followed by phenol-chloroform RNA extraction. Mammalian rRNA was subsequently removed using the procedures described for the RiboZero Magnetic Gold kit (Epicentre). Ribosome footprints are expected to be 28-30 nt long.
To recover fragments in this exact size window, purified fragments were resolved under denaturing PAGE. Following adaptor ligation, reverse transcription and a second denaturing PAGE purification, samples were circularized. Ribo-seq libraries were amplified by PCR (12 cycles) using the circularized products as template. PCR-amplified libraries were purified on native 8% polyacrylamide gels and quantified using the Qubit fluorometer. The quality and average fragment size of the libraries were instead assessed with the Bioanalyzer High-Sensitivity Assay (Agilent Technologies).
To reduce technical biases, samples were barcoded and pooled to perform multiplex sequencing on the HiSeq 2000 platform (single-end, 50-bp sequencing chemistry).
To assess transcript abundance, stranded poly(A) + RNA-seq was performed following standard instructions from the manufacturer (TruSeq Stranded mRNA-seq Library Prep kit), using 1 µg of total RNA as input. Libraries were pooled and sequenced on a HiSeq 2000 instrument (paired-end, 100-bp sequencing chemistry).
Read mapping. We used Illumina CASAVA 1.8 software to demultiplex all reads and convert bcl files to fastq files. We then clipped adaptors from the Ribo-seq cDNA inserts using the FASTX-Toolkit (http://hannonlab.cshl.edu/ fastx_toolkit/index.html). Adaptors were clipped using the command fastx_clipper-aAGATCGGAAGAGCACACGTCT-l20-n-v-Q33| fastx_trimmer-Q33-f1
We then processed the RNA-seq reads in a similar manner and trimmed them to a length of 29 bp, the most abundant read length found in Ribo-seq, using the command
fastx_trimmer-l29-Q33
Trimming the RNA-seq data before mapping ensures that we can compare the two methodologies and draw conclusions regarding translational regulation. This step avoids differences in expression estimates that arise because of technical differences between the methods. We then removed mitochondrial RNA and rRNA sequences from all libraries using the Bowtie 48, 49 with the command bowtie -l 20 --un clean.fastq /abundant_sequences input.fastq-Sabundant.sam Abundant sequences were stored in a Bowtie index derived from the fastq files for the rat mitochondrial genome and rRNA sequences annotated in the Ensembl database 50 . Sequences that did not align (clean.fastq) were then further mapped to the genome using TopHat 2.0. 13 (ref. 51) with the rn5 genome tophat2--read-realign-edit-dist0-p6-z0-M-j HiQual.juncs-GRattus_norvegicus.Rnor_5.0.79_TTN.gtfrn5 R1.fastq
To improve the mapping of these short reads, we introduced splicing junctions as described previously 15 . We also supplied Ensembl 50 rat genome annotation v79 to the mapping pipeline. Ttn is not well annotated in rat, so we decided to lift over human TTN to the rat genome. We used the liftOver tool of the Galaxy 52, 53 platform with standard parameters to transfer the TTN transcript model 3 to the rn5 genome. Split reads in RNA-seq data were used to confirm exon boundaries in rat. Titin regions and domains are shown as reported previously in human 3 . The Ensembl gene IDs corresponding to parts of titin were removed from the annotation and replaced with our custom titin annotation before the mapping step, which was then used for all analyses further downstream.
To analyze alternative splicing, we did not trim the RNA-seq reads but used the full-length 2 × 100-bp paired-end data to improve the estimation of splice-site usage in rat with the command tophat2--read-realign-edit-dist0-p6--no-coverage-search-M-jHiQual.juncs-GRattus_norvegicus. Rnor_5.0.79_TTN.gtfrn5R1.fastqR2.fastq
Read periodicity.
To determine the quality of the Ribo-seq data, we calculated the percentage of reads starting at a position that was indicative for ribosomes located on a codon of the ORF. We first selected 29-mers and then extracted the position of the A of the ATG start codon. This position is indicated by the location of the 5′ UTRs annotated by Ensembl 50 Biomart. Plotting the start positions of 29-mers in a window around the ATG codons of known genes showed a peak of read starts 12 bp upstream of the start codon. This is indicative for ribosomes located at the translation start site. Subsequently, read starts were preferentially located periodically every 3 bp, representing actively translating ribosomes reading the genetic message while synthesizing new protein. All libraries generated showed very high periodicity, with more than 90% of reads located in frame.
To determine whether the ribosomes localized to Ttn after the truncation in TTNtvZ rats are translating canonical titin sequence, we first determined the coding frame for each exon in wild-type rats. We then compared the percentage of reads located in this frame in wild-type and TTNtvZ rats and did not detect a difference across the locus. This indicates that ribosomes associated with the truncated titin isoforms are located in frame. We only determined periodicity in cardiac exons that were covered by at least ten read starts to avoid noise due to low coverage.
Gene expression analyses.
To assess gene transcription and translation levels, we counted uniquely mapping reads that were unambiguously assigned to one gene with htseq-count using the command htseq-count --stranded=no --type=CDS --quiet --idattr=gene_id -Rattus_norvegicus.Rnor_5.0.79_
TTN.gtf
We only considered reads mapping to the coding sequence of genes annotated in Ensembl database v79 (ref. 50) for both the Ribo-seq and RNA-seq data sets. To detect genes differentially expressed between genotypes, we used the DESeq2 package 54 with standard parameters (false discovery rate (FDR) ≤ 0.05) for comparison of the two TTNtv models to wild-type rats. All genes that were detected in any of the comparisons are reported in the Supplementary Figure  6 and Supplementary Table 1 ).
Gene and exon expression levels are given in RPKM. Reads overlapping a feature were normalized to the length of the feature and the number of uniquely mapping reads (that is, sequencing depth). Unlike read counts, these values can be used to compare RNA expression levels for different features within the same sample.
To assess allele-specific transcription and translation, we first identified all F344 SNPs on the BN background annotated by the rat genome database 55 that overlapped with the Ttn locus (http://rgd.mcw.edu/). We then counted the reads overlapping these positions and assigned them to either the BN or F344 allele depending on their sequence. Allele frequency across these positions corresponds to the ratio of Ttn transcripts originating from non-truncated Ttn (BN) and truncated Ttn (F344) in the TTNtv models.
The sum of the number of reads assigned to the BN or F344 allele was calculated for each rat, normalized by library size; these sums were then compared between wild-type and TTNtvA or TTNtvZ rats. To avoid BN-or F344-specific differences in Ttn expression disturbing signal, we normalized the expression levels of both alleles to the levels in wild-type rats.
To assess protein synthesis levels for full-length titin, we considered all Ribo-seq reads that we could assign to regions exclusive to the non-truncated alleles in TTNtv rats and compared counts to those for wild-type rats. In TTNtvA rats, all Ribo-seq reads located after the premature stop codon are derived from the BN allele. This is indicated by the complete absence of F344 SNPs in the data due to efficient stop of translation after the premature stop codon. The proximal truncation in TTNtvZ rats does not completely stop translation, and Ribo-seq reads downstream of the premature stop codon are not necessarily representative of expression of full-length titin. These reads partly derive from isoforms with alternative N termini that are not truncated by the TTNtvZ mutation. Anticipating this, we chose to generate a stop by introducing a large deletion that encompassed several exons. These exons (exons 3-5) are only present in the BN allele, and reads mapping to this region are thus indicative of expression of full-length titin in the absence of a truncation in TTNtvZ rats.
We also assessed the translation of each exonic part of Ttn across all rat models. We only considered exons with an expression level of RPKM >1 in rat heart (n = 237). FPKM values from all three replicates for each TTNtv model were compared to those for wild-type rats, and outliers were removed (ROUT Q = 1%). We then calculated the average ratio for each exon across all biological replicates and performed second-order polynomial smoothing using ten neighbors to generate the average. Smoothing was required to visualize a trend of translation rates in comparison to healthy rats across the entire Ttn locus.
To assess allele frequency in the RNA-seq and Ribo-seq data, we required the location of each F344 SNP (n = 121) to be covered by at least two reads on average across all rats.
Detection of alternative transcription start site expression in human heart.
To identify transcription start sites in TTN, two sources of data were used. First, CAGE data from heart tissue in the FANTOM5 consortium data set 13 were used to identify the location of active transcription start sites. Second, ChIP-seq data were used from heart tissue for two histone marks associated with the presence of an active promoter, namely H3K4me3 and H3K9ac, in the Epigenomics Roadmap data set 16 . Specifically, the FANTOM5 heart samples were CNhs11758, CNhs11757, CNhs10621, CNhs10653, CNhs12855, CNhs12856 and CNhs12857, for which data were downloaded using CAGEr 56 . These data were then processed using CAGEr (standard parameters) to identify transcription start sites by first normalizing the tag counts using a power law and then clustering the reads to find CAGE peaks that corresponded to active transcription start sties. This approach identified three transcription start sites within the TTN region. To further validate these sites, narrow H3K4me3 peaks from sample E095 (adult heart left ventricle) and narrow H3K9ac peaks and narrow H3K4me3 peaks from sample E083 (fetal heart) were downloaded from the Epigenomics Roadmap data portal and overlaid onto TTN. This showed corresponding histone modifications for two of the three transcription start sites identified using CAGEr. All of these data sets were then plotted using circlize 57 .
Percent spliced in. To assess splicing of Ttn in TTNtv hearts, we calculated the PSI ratio for all exons in TTN across species. PSI is a measure of how efficiently an exon is spliced into the final isoform population of a gene. First, we generated an exonic matrix based on our custom Ttn annotation using the prepare_annotation tool 58 . Then, we executed the PSI.sh 17 script to calculate PSI ratios with the following parameters: 15 U/ml DNase I, and protease and phosphatase inhibitors). The primary and secondary extracts were combined, and protein concentration was determined by BCA protein assay (Pierce, Thermo Scientific). Equal amounts of protein were separated by SDS-PAGE, transferred to PVDF membranes and probed with antibody to mTOR pSer2448 (2971), 4EBP1 pThr37/Thr46 (2855), S6K pThr389 (9205), mTOR (2972), S6K (2708), 4EBP1 (9644), GAPDH (2118) or β-tubulin (2146) from Cell Signaling Technology. All antibodies were diluted at 1:1,000.
Healthy volunteer magnetic resonance imaging. Healthy volunteers without self-reported cardiovascular disease or a family history of disease were recruited prospectively via advertisement to the UK Digital Heart Project (https://digital-heart.org/) at the MRC-CSC, Imperial College, London 69 . The study was approved by a research ethics committee, and all participants gave written informed consent.
Conventional 2D and high-resolution 3D cine balanced steady-state free precession (b-SSFP) CMR imaging were performed on a 1.5T Philips Achieva system (Best) 41 . Analysis of the CMR scans was carried out by two experienced cardiologists, blinded to genotyping data, using commercially available semiautomated software (CMRtools, Cardiovascular Imaging Solutions). Measurements followed standard methodology 70, 71 , with papillary muscles included in the left ventricular mass and valve position tracked in the long-axis images. 3D CMR data were segmented and co-registered to provide a model of phenotypic variation in the population 42 .
Statistical analysis. GraphPad Prism 6 software was used for statistical analysis. For two factors, trend testing was performed with two-way ANOVA. Comparison of two means was performed by two-tailed t test. When several conditions were each compared to one reference condition, we performed Dunnett's test to correct for multiple testing. Data are reported as means ± s.e.m. or s.d. as described 42 , with significance levels of *P < 0.05, **P < 0.01 and ***P < 0.001. Using RStudio Server version 0.98, standard linear regressions were performed to evaluate the relationship between TTNtv genotype and cardiovascular phenotypes, as previously described 3 . Multivariate models were generated using known clinical covariates and optimized to minimize the Bayesian information criterion. The relationships between morphological parameters and TTN genotype were assessed by ANOVA between nested linear models. To test for position-independent association of TTNtv across TTN, we performed binomial tests. 3D phenotypic regression modeling applied threshold-free cluster enhancement and permutation testing to derive the P values associated with each regression coefficient following adjustment to control the FDR 72, 73 .
Data availability. The RNA-seq and Ribo-seq data used in the manuscript can be obtained from the European Nucleotide Archive (ENA) under accession ERP015402.
